MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Conceptus, Inc. (NASDAQ:CPTS) today announced the approval of its third generation Essure® permanent birth control system by the U.S. Food and Drug Administration (FDA). System modifications include changes to the delivery system that reduce the number of steps a physician is required to perform during a placement procedure.
